Trial intelligence / Profile preview

ABL001 vs BAT in CML-CP after ≥2 TKIs (China)

CTR20212457Phase 2Completed

Sponsor

Novartis

Start

Sep 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1